FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adrian Park

Research Profile

Physiology

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Anatomy

Adipose Tissue

Co-author Network

Publications

TOP 3
David R Jesudason; Mariana P Monteiro; B M C McGowan; Nicola M Neary; Adrian J Park; Elena Philippou; Caroline J Small; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Low-dose pancreatic polypeptide inhibits food intake in man.
Katie Wynne; Adrian J Park; Caroline J Small; Karim Meeran; Mohammad A Ghatei; Gary S Frost; Stephen R Bloom
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial.
Nicola M Neary; Caroline J Small; Maralyn R Druce; Adrian J Park; Sandra M Ellis; Nina M Semjonous; Catherine L Dakin; Karin Filipsson; Fang Wang; Aysha S Kent; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adrian Park (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: David R Jesudason; Mariana P Monteiro; B M C McGowan; Nicola M Neary; Adrian J Park; Elena Philippou; Caroline J Small; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Low-dose pancreatic polypeptide inhibits food intake in man.
The British journal of nutrition 2007;97(3):426-9.
2006: Katie Wynne; Adrian J Park; Caroline J Small; Karim Meeran; Mohammad A Ghatei; Gary S Frost; Stephen R Bloom
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial.
International journal of obesity (2005) 2006;30(12):1729-36.
2005: Nicola M Neary; Caroline J Small; Maralyn R Druce; Adrian J Park; Sandra M Ellis; Nina M Semjonous; Catherine L Dakin; Karin Filipsson; Fang Wang; Aysha S Kent; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Endocrinology 2005;146(12):5120-7.
2005: Maralyn R Druce; Alison M Wren; Adrian J Park; J E Milton; Michael Patterson; Gary Frost; Mohammad A Ghatei; Caroline Small; Stephen R Bloom
Ghrelin increases food intake in obese as well as lean subjects.
International journal of obesity (2005) 2005;29(9):1130-6.
2005: Katie Wynne; Adrian J Park; Caroline J Small; Michael Patterson; Sandra M Ellis; Kevin G Murphy; Alison M Wren; Gary S Frost; Karim Meeran; Mohammad A Ghatei; Stephen R Bloom
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.
Diabetes 2005;54(8):2390-5.
2005: Adrian J Park; Stephen R Bloom
Neuroendocrine control of food intake.
Current opinion in gastroenterology 2005;21(2):228-33.
2003: Rachel L Batterham; Carel W le Roux; Mark A Cohen; Adrian J Park; Sandra M Ellis; Michael Patterson; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Pancreatic polypeptide reduces appetite and food intake in humans.
The Journal of clinical endocrinology and metabolism 2003;88(8):3989-92.
2002: Catherine L Dakin; Caroline J Small; Adrian J Park; Asha Seth; Mohammad A Ghatei; Stephen R Bloom
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats.
American journal of physiology. Endocrinology and metabolism 2002;283(6):E1173-7.